| Year |
Citation |
Score |
| Low-probability matches (unlikely to be authored by this person) |
| 2015 |
Raffi F, Rachlis A, Brinson C, Arasteh K, Górgolas M, Brennan C, Pappa K, Almond S, Granier C, Nichols WG, Cuffe RL, Eron J, Walmsley S. Dolutegravir efficacy at 48 weeks in key subgroups of treatment-naive HIV-infected individuals in three randomized trials. Aids (London, England). 29: 167-74. PMID 25387312 DOI: 10.1097/Qad.0000000000000519 |
0.298 |
|
| 2010 |
Singhal N, Fergusson D, Huff H, Mills EJ, la Porte C, Walmsley S, Cameron DW. Design and methods of the MAINTAIN study: a randomized controlled clinical trial of micronutrient and antioxidant supplementation in untreated HIV infection. Contemporary Clinical Trials. 31: 604-11. PMID 20708714 DOI: 10.1016/J.Cct.2010.08.003 |
0.291 |
|
| 2007 |
Tan D, Walmsley S. Lopinavir plus ritonavir: A novel protease inhibitor combination for HIV infections Expert Review of Anti-Infective Therapy. 5: 13-28. PMID 17266450 DOI: 10.1586/14787210.5.1.13 |
0.289 |
|
| 2008 |
Marr P, Walmsley S. Reassessment of enfuvirtide's role in the management of HIV-1 infection Expert Opinion On Pharmacotherapy. 9: 2349-2362. PMID 18710359 DOI: 10.1517/14656566.9.13.2349 |
0.289 |
|
| 2014 |
Tan DH, Raboud JM, Kaul R, Walmsley SL. Antiretroviral therapy is not associated with reduced herpes simplex virus shedding in HIV coinfected adults: an observational cohort study. Bmj Open. 4: e004210. PMID 24464523 DOI: 10.1136/Bmjopen-2013-004210 |
0.281 |
|
| 2013 |
Walmsley SL, Antela A, Clumeck N, Duiculescu D, Eberhard A, Gutiérrez F, Hocqueloux L, Maggiolo F, Sandkovsky U, Granier C, Pappa K, Wynne B, Min S, Nichols G. Dolutegravir plus abacavir-lamivudine for the treatment of HIV-1 infection. The New England Journal of Medicine. 369: 1807-18. PMID 24195548 DOI: 10.1056/NEJMoa1215541 |
0.28 |
|
| 2015 |
Sharma M, Walmsley SL. Contraceptive options for HIV-positive women: making evidence-based, patient-centred decisions. Hiv Medicine. 16: 329-36. PMID 25689044 DOI: 10.1111/Hiv.12221 |
0.28 |
|
| 2008 |
Kaul R, Pettengell C, Sheth PM, Sunderji S, Biringer A, MacDonald K, Walmsley S, Rebbapragada A. The genital tract immune milieu: an important determinant of HIV susceptibility and secondary transmission Journal of Reproductive Immunology. 77: 32-40. PMID 17395270 DOI: 10.1016/J.Jri.2007.02.002 |
0.279 |
|
| 2010 |
Tan DH, Raboud JM, Kaul R, Grinsztejn B, Cahn P, Walmsley SL. Can herpes simplex virus type 2 suppression slow HIV disease progression: a study protocol for the VALacyclovir In Delaying Antiretroviral Treatment Entry (VALIDATE) trial. Trials. 11: 113. PMID 21106086 DOI: 10.1186/1745-6215-11-113 |
0.278 |
|
| 2007 |
Walmsley SL, Thorne A, Loutfy MR, LaPierre N, MacLeod J, Harrigan R, Trottier B, Conway B, Hay JR, Singer J, Zarowny D. A prospective randomized controlled trial of structured treatment interruption in HIV-infected patients failing highly active antiretroviral therapy (Canadian HIV Trials Network Study 164). Journal of Acquired Immune Deficiency Syndromes (1999). 45: 418-25. PMID 17468667 DOI: 10.1097/QAI.0b013e318061b611 |
0.278 |
|
| 2014 |
Klein MB, Young J, Dunn D, Ledergerber B, Sabin C, Cozzi-Lepri A, Dabis F, Harrigan R, Tan DH, Walmsley S, Gill J, Cooper C, Scherrer AU, Mocroft A, Hogg RS, et al. The effects of HIV-1 subtype and ethnicity on the rate of CD4 cell count decline in patients naive to antiretroviral therapy: a Canadian-European collaborative retrospective cohort study. Cmaj Open. 2: E318-29. PMID 25485259 DOI: 10.9778/cmajo.20140017 |
0.275 |
|
| 2009 |
Grennan T, Walmsley S. Etravirine for HIV-I: Addressing the limitations of the nonnucleoside reverse transcriptase inhibitor class Journal of the International Association of Physicians in Aids Care. 8: 354-363. PMID 19855100 DOI: 10.1177/1545109709347373 |
0.275 |
|
| 2008 |
Hammer SM, Eron JJ, Reiss P, Schooley RT, Thompson MA, Walmsley S, Cahn P, Fischl MA, Gatell JM, Hirsch MS, Jacobsen DM, Montaner JS, Richman DD, Yeni PG, Volberding PA, et al. Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel. Jama. 300: 555-70. PMID 18677028 DOI: 10.1001/jama.300.5.555 |
0.272 |
|
| 2013 |
Yi TJ, Walmsley S, Szadkowski L, Raboud J, Rajwans N, Shannon B, Kumar S, Kain KC, Kaul R, Tan DH. A randomized controlled pilot trial of valacyclovir for attenuating inflammation and immune activation in HIV/herpes simplex virus 2-coinfected adults on suppressive antiretroviral therapy. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 57: 1331-8. PMID 23946220 DOI: 10.1093/Cid/Cit539 |
0.272 |
|
| 2006 |
Aghdassi E, Salit IE, Fung L, Sreetharan L, Walmsley S, Allard JP. Is chromium an important element in HIV-positive patients with metabolic abnormalities? An hypothesis generating pilot study Journal of the American College of Nutrition. 25: 56-63. PMID 16522933 DOI: 10.1080/07315724.2006.10719515 |
0.271 |
|
| 2013 |
Eron JJ, Clotet B, Durant J, Katlama C, Kumar P, Lazzarin A, Poizot-Martin I, Richmond G, Soriano V, Ait-Khaled M, Fujiwara T, Huang J, Min S, Vavro C, Yeo J, Walmsley SL, et al. Safety and efficacy of dolutegravir in treatment-experienced subjects with raltegravir-resistant HIV type 1 infection: 24-Week results of the VIKING study Journal of Infectious Diseases. 207: 740-748. PMID 23225901 DOI: 10.1093/infdis/jis750 |
0.269 |
|
| 2013 |
Tan DH, Raboud JM, Kaul R, Brunetta J, Kaushic C, Kovacs C, Lee E, Luetkehoelter J, Rachlis A, Smaill F, Smieja M, Walmsley SL. Herpes simplex virus type 2 coinfection does not accelerate CD4 count decline in untreated HIV infection. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 57: 448-57. PMID 23572481 DOI: 10.1093/Cid/Cit208 |
0.268 |
|
| 2012 |
Nadarajah JT, Collins M, Raboud J, Su D, Rao K, Loutfy MR, Walmsley S. Infectious complications of Bio-Alcamid filler used for HIV-related facial lipoatrophy. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 55: 1568-74. PMID 22942210 DOI: 10.1093/Cid/Cis745 |
0.266 |
|
| 2016 |
Andany N, Walmsley SL. What's new for antiretroviral treatment in women with HIV. Journal of Virus Eradication. 2: 67-77. PMID 27482438 |
0.264 |
|
| 2013 |
Tan DH, Murphy K, Shah P, Walmsley SL. Herpes simplex virus type 2 and HIV disease progression: a systematic review of observational studies. Bmc Infectious Diseases. 13: 502. PMID 24164861 DOI: 10.1186/1471-2334-13-502 |
0.264 |
|
| 2011 |
Tan DH, Chan K, Raboud J, Cooper C, Montaner JS, Walmsley S, Hogg RS, Klein MB, Machouf N, Rourke SB, Tsoukas C, Loutfy MR. Comparison of abacavir/lamivudine and tenofovir/emtricitabine among treatment-naive HIV-infected patients initiating therapy. Journal of Acquired Immune Deficiency Syndromes (1999). 58: 38-46. PMID 21709570 DOI: 10.1097/Qai.0B013E3182282Cfc |
0.26 |
|
| 2014 |
Sharma M, Walmsley SL. Raltegravir as antiretroviral therapy in HIV/AIDS. Expert Opinion On Pharmacotherapy. 15: 395-405. PMID 24304203 DOI: 10.1517/14656566.2014.868884 |
0.259 |
|
| 2007 |
Tinmouth J, Kandel G, Tomlinson G, Walmsley S, Steinhart AH, Glazier R. Systematic review of strategies to measure HIV-related diarrhea Hiv Clinical Trials. 8: 155-163. PMID 17621462 DOI: 10.1310/Hct0803-155 |
0.257 |
|
| 2016 |
Shuper PA, Joharchi N, Irving H, Fletcher D, Kovacs C, Loutfy M, Walmsley SL, Wong DK, Rehm J. Differential predictors of ART adherence among HIV-monoinfected versus HIV/HCV-coinfected individuals. Aids Care. 1-9. PMID 26971360 DOI: 10.1080/09540121.2016.1158396 |
0.255 |
|
| 2010 |
Klein MB, Saeed S, Yang H, Cohen J, Conway B, Cooper C, Côté P, Cox J, Gill J, Haase D, Haider S, Montaner J, Pick N, Rachlis A, Rouleau D, ... Walmsley S, et al. Cohort profile: the Canadian HIV-hepatitis C co-infection cohort study. International Journal of Epidemiology. 39: 1162-9. PMID 19786463 DOI: 10.1093/Ije/Dyp297 |
0.255 |
|
| 2013 |
Tan DH, Walmsley SL. Management of persons infected with human immunodeficiency virus requiring admission to the intensive care unit. Critical Care Clinics. 29: 603-20. PMID 23830655 DOI: 10.1016/j.ccc.2013.03.010 |
0.254 |
|
| 2007 |
Walmsley S. Protease inhibitor-based regimens for HIV therapy: Safety and efficacy Journal of Acquired Immune Deficiency Syndromes. 45: S5-S13. PMID 17525691 DOI: 10.1097/Qai.0B013E3180600709 |
0.254 |
|
| 2015 |
Walmsley S, Baumgarten A, Berenguer J, Felizarta F, Florence E, Khuong-Josses MA, Kilby JM, Lutz T, Podzamczer D, Portilla J, Roth N, Wong D, Granier C, Wynne B, Pappa K. Dolutegravir Plus Abacavir/Lamivudine for the Treatment of HIV-1 Infection in Antiretroviral Therapy-Naive Patients: Week 96 and Week 144 Results from the SINGLE Randomized Clinical Trial. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 26262777 DOI: 10.1097/QAI.0000000000000790 |
0.253 |
|
| 2015 |
Cooper C, Rollet-Kurhajec KC, Young J, Vasquez C, Tyndall M, Gill J, Pick N, Walmsley S, Klein MB. HIV virological rebounds but not blips predict liver fibrosis progression in antiretroviral-treated HIV/hepatitis C virus-coinfected patients. Hiv Medicine. 16: 24-31. PMID 24837567 DOI: 10.1111/Hiv.12168 |
0.252 |
|
| 2016 |
Kis O, Sankaran-Walters S, Hoque MT, Walmsley SL, Dandekar S, Bendayan R. HIV-1 Alters Intestinal Expression of Drug Transporters and Metabolic Enzymes: Implications in Antiretroviral Drug Disposition. Antimicrobial Agents and Chemotherapy. PMID 26902756 DOI: 10.1128/Aac.02278-15 |
0.251 |
|
| 2011 |
Molina JM, Cahn P, Grinsztejn B, Lazzarin A, Mills A, Saag M, Supparatpinyo K, Walmsley S, Crauwels H, Rimsky LT, Vanveggel S, Boven K. Rilpivirine versus efavirenz with tenofovir and emtricitabine in treatment-naive adults infected with HIV-1 (ECHO): a phase 3 randomised double-blind active-controlled trial. Lancet. 378: 238-46. PMID 21763936 DOI: 10.1016/S0140-6736(11)60936-7 |
0.251 |
|
| 2007 |
Cavalcanti RB, Raboud J, Shen S, Kain KC, Cheung A, Walmsley S. A randomized, placebo-controlled trial of rosiglitazone for HIV-related lipoatrophy. The Journal of Infectious Diseases. 195: 1754-61. PMID 17492590 DOI: 10.1086/518005 |
0.25 |
|
| 2012 |
Rebick G, Walmsley SL. Issues in resistance, adherence, and comparative efficacy of the single-tablet regimen combination of tenofovir, emtricitabine, and efavirenz in the management of HIV-1 infection gabriel rebick Virus Adaptation and Treatment. 4: 51-63. DOI: 10.2147VAAT.S12706 |
0.249 |
|
| 2014 |
Balfour L, Spaans JN, Fergusson D, Huff H, Mills EJ, la Porte CJ, Walmsley S, Singhal N, Rosenes R, Tremblay N, Gill MJ, Loemba H, Conway B, Rachlis A, Ralph E, et al. Micronutrient deficiency and treatment adherence in a randomized controlled trial of micronutrient supplementation in ART-naïve persons with HIV. Plos One. 9: e85607. PMID 24465617 DOI: 10.1371/Journal.Pone.0085607 |
0.249 |
|
| 2007 |
Loutfy MR, Ackad N, Antoniou T, Baril JG, Conway B, de Wet J, Trottier B, Kovacs CM, Thompson W, Martel AY, Trottier S, Rouleau D, Shafran SD, Rachlis A, Fraser C, ... Walmsley SL, et al. Randomized controlled trial of once-daily tenofovir, lamivudine, and lopinavir/ritonavir versus remaining on the same regimen in virologically suppressed HIV-infected patients on their first PI-containing HAART regimen. Hiv Clinical Trials. 8: 259-68. PMID 17956827 DOI: 10.1310/Hct0805-259 |
0.248 |
|
| 2007 |
Tinmouth J, Tomlinson G, Kandel G, Walmsley S, Steinhart AH, Glazier R. Evaluation of stool frequency and stool form as measures of HIV-related diarrhea Hiv Clinical Trials. 8: 421-428. PMID 18042507 DOI: 10.1310/Hct0806-421 |
0.248 |
|
| 2006 |
Gathe J, Cooper DA, Farthing C, Jayaweera D, Norris D, Pierone G, Steinhart CR, Trottier B, Walmsley SL, Workman C, Mukwaya G, Kohlbrenner V, Dohnanyi C, McCallister S, Mayers D, et al. Efficacy of the protease inhibitors tipranavir plus ritonavir in treatment-experienced patients: 24-week analysis from the RESIST-1 trial. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 43: 1337-46. PMID 17051503 DOI: 10.1086/508353 |
0.247 |
|
| 2016 |
Burchell AN, Allen VG, Grewal R, MacPherson PA, Rachlis A, Walmsley S, Mishra S, Gardner SL, Raboud J, Cooper C, Gough K, Rourke SB, Rousseau R, Salit I, Tan DH. Enhanced syphilis screening among HIV-positive men (ESSAHM): a study protocol for a clinic-randomized trial with stepped wedge design. Implementation Science : Is. 11: 8. PMID 26772390 DOI: 10.1186/S13012-016-0371-0 |
0.246 |
|
| 2015 |
Tan DH, Szadkowski L, Raboud J, Yi TJ, Shannon B, Kaul R, Liles WC, Walmsley S. Effect of Intercurrent Infections and Vaccinations on Immune and Inflammatory Biomarkers Among Human Immunodeficiency Virus-Infected Adults on Suppressive Antiretroviral Therapy. Open Forum Infectious Diseases. 2: ofv036. PMID 26380337 DOI: 10.1093/Ofid/Ofv036 |
0.245 |
|
| 2012 |
Lake JE, McComsey GA, Hulgan TM, Wanke CA, Mangili A, Walmsley SL, Boger MS, Turner RR, McCreath HE, Currier JS. A randomized trial of Raltegravir replacement for protease inhibitor or non-nucleoside reverse transcriptase inhibitor in HIV-infected women with lipohypertrophy. Aids Patient Care and Stds. 26: 532-40. PMID 22823027 DOI: 10.1089/apc.2012.0135 |
0.24 |
|
| 2016 |
Cox J, Hamelin AM, McLinden T, Moodie EE, Anema A, Rollet-Kurhajec KC, Paradis G, Rourke SB, Walmsley SL, Klein MB. Food Insecurity in HIV-Hepatitis C Virus Co-infected Individuals in Canada: The Importance of Co-morbidities. Aids and Behavior. PMID 26912217 DOI: 10.1007/S10461-016-1326-9 |
0.24 |
|
| 2015 |
Kandel CE, Walmsley SL. Dolutegravir - a review of the pharmacology, efficacy, and safety in the treatment of HIV. Drug Design, Development and Therapy. 9: 3547-55. PMID 26185421 DOI: 10.2147/DDDT.S84850 |
0.239 |
|
| 2015 |
Patterson S, Cescon A, Samji H, Chan K, Zhang W, Raboud J, Burchell AN, Cooper C, Klein MB, Rourke SB, Loutfy MR, Machouf N, Montaner JSG, Tsoukas C, Hogg RS, ... Walmsley S, et al. Life expectancy of HIV-positive individuals on combination antiretroviral therapy in Canada Bmc Infectious Diseases. 15. DOI: 10.1186/s12879-015-0969-x |
0.239 |
|
| 2014 |
Johnson M, Walmsley S, Haberl A. A systematic review of the use of atazanavir in women infected with HIV-1. Antiviral Therapy. 19: 293-307. PMID 24480797 DOI: 10.3851/Imp2742 |
0.238 |
|
| 2010 |
Rachlis A, Harris M, Lalonde R, Shafran SD, Tremblay C, Wainberg MA, Walmsley S. Canadian consensus guidelines for the optimal use of maraviroc in the treatment of HIV-infected adults Canadian Journal of Infectious Diseases and Medical Microbiology. 21: 159-172. |
0.237 |
|
| 2014 |
Lake JE, McComsey GA, Hulgan T, Wanke CA, Mangili A, Walmsley SL, Stramotas SA, Tracy R, Currier JS. Switch to raltegravir decreases soluble CD14 in virologically suppressed overweight women: the Women, Integrase and Fat Accumulation Trial. Hiv Medicine. 15: 431-41. PMID 24506429 DOI: 10.1111/hiv.12128 |
0.236 |
|
| 2014 |
Cooper DA, Heera J, Ive P, Botes M, Dejesus E, Burnside R, Clumeck N, Walmsley S, Lazzarin A, Mukwaya G, Saag M, van Der Ryst E. Efficacy and safety of maraviroc vs. efavirenz in treatment-naive patients with HIV-1: 5-year findings. Aids (London, England). 28: 717-25. PMID 24983542 DOI: 10.1097/Qad.0000000000000131 |
0.235 |
|
| 2013 |
Loutfy MR, Walmsley SL, Klein MB, Raboud J, Tseng AL, Blitz SL, Pick N, Conway B, Angel JB, Rachlis AR, Gough K, Cohen J, Haase D, Burdge D, Smaill FM, et al. Factors affecting antiretroviral pharmacokinetics in HIV-infected women with virologic suppression on combination antiretroviral therapy: a cross-sectional study. Bmc Infectious Diseases. 13: 256. PMID 23732043 DOI: 10.1186/1471-2334-13-256 |
0.231 |
|
| 2016 |
Baril JG, Angel JB, Gill MJ, Gathe J, Cahn P, van Wyk J, Walmsley S. Dual Therapy Treatment Strategies for the Management of Patients Infected with HIV: A Systematic Review of Current Evidence in ARV-Naive or ARV-Experienced, Virologically Suppressed Patients. Plos One. 11: e0148231. PMID 26849060 DOI: 10.1371/Journal.Pone.0148231 |
0.231 |
|
| 2012 |
Szadkowski L, Tseng A, Walmsley SL, Salit I, Raboud JM. Short communication: effects of age on virologic suppression and CD4 cell response in HIV-positive patients initiating combination antiretroviral therapy. Aids Research and Human Retroviruses. 28: 1579-83. PMID 22734840 DOI: 10.1089/AID.2012.0018 |
0.231 |
|
| 2014 |
Loutfy MR, Blitz S, Zhang Y, Hart TA, Walmsley SL, Smaill FM, Rachlis AR, Yudin MH, Angel JB, Ralph ED, Tharao W, Raboud JM. Self-Reported Preconception Care of HIV-Positive Women of Reproductive Potential: A Retrospective Study. Journal of the International Association of Providers of Aids Care. 13: 424-33. PMID 23918921 DOI: 10.1177/2325957413494238 |
0.231 |
|
| 2015 |
Papp E, Mohammadi H, Loutfy MR, Yudin MH, Murphy KE, Walmsley SL, Shah R, MacGillivray J, Silverman M, Serghides L. HIV protease inhibitor use during pregnancy is associated with decreased progesterone levels, suggesting a potential mechanism contributing to fetal growth restriction. The Journal of Infectious Diseases. 211: 10-8. PMID 25030058 DOI: 10.1093/Infdis/Jiu393 |
0.23 |
|
| 2010 |
Raboud JM, Loutfy MR, Su D, Bayoumi AM, Klein MB, Cooper C, Machouf N, Rourke S, Walmsley S, Rachlis A, Harrigan PR, Smieja M, Tsoukas C, Montaner JS, Hogg RS, et al. Regional differences in rates of HIV-1 viral load monitoring in Canada: Insights and implications for antiretroviral care in high income countries. Bmc Infectious Diseases. 10: 40. PMID 20184766 DOI: 10.1186/1471-2334-10-40 |
0.23 |
|
| 2009 |
Walmsley SL, Squires K, Weiss L, Easterbrook P, Orani A, Kraft M, Scherer J. Multidrug-experienced HIV-1-infected women demonstrated similar virological and immunological responses to tipranavir/ritonavir compared with men. Aids (London, England). 23: 429-31. PMID 19114862 DOI: 10.1097/QAD.0b013e3283229f81 |
0.23 |
|
| 2009 |
Loutfy MR, Hart TA, Mohammed SS, Su D, Ralph ED, Walmsley SL, Soje LC, Muchenje M, Rachlis AR, Smaill FM, Angel JB, Raboud JM, Silverman MS, Tharao WE, Gough K, et al. Fertility desires and intentions of HIV-positive women of reproductive age in Ontario, Canada: a cross-sectional study. Plos One. 4: e7925. PMID 19997556 DOI: 10.1371/Journal.Pone.0007925 |
0.23 |
|
| 2010 |
Raboud J, Blitz S, Walmsley S, Thompson C, Rourke SB, Loutfy MR. Effect of gender and calendar year on time to and duration of virologic suppression among antiretroviral-naïve HIV-infected individuals initiating combination antiretroviral therapy. Hiv Clinical Trials. 11: 340-50. PMID 21239362 DOI: 10.1310/Hct1106-340 |
0.229 |
|
| 2008 |
Mishra S, Walmsley SL, Loutfy MR, Kaul R, Logue KJ, Gold WL. Otosyphilis in HIV-coinfected individuals: A case series from Toronto, Canada Aids Patient Care and Stds. 22: 213-219. PMID 18290755 DOI: 10.1089/Apc.2007.0019 |
0.228 |
|
| 2009 |
Romanowski B, Myziuk LN, Walmsley SL, Trottier S, Singh AE, Houston S, Joffe M, Chiu I. Seroprevalence and risk factors for herpes simplex virus infection in a population of HIV-infected patients in Canada. Sexually Transmitted Diseases. 36: 165-9. PMID 19098690 DOI: 10.1097/OLQ.0b013e31818d3fb6 |
0.228 |
|
| 2010 |
Suleiman J, Zingman BS, Diaz RS, Madruga JV, DeJesus E, Slim J, Mak C, Lee E, McCarthy MC, Dunkle LM, Walmsley S. Vicriviroc in combination therapy with an optimized regimen for treatment-experienced subjects: 48-week results of the VICTOR-E1 phase 2 trial. The Journal of Infectious Diseases. 201: 590-9. PMID 20064072 DOI: 10.1086/650342 |
0.227 |
|
| 2013 |
Klein MB, Rollet KC, Saeed S, Cox J, Potter M, Cohen J, Conway B, Cooper C, Côté P, Gill J, Haase D, Haider S, Hull M, Moodie E, Montaner J, ... Walmsley S, et al. HIV and hepatitis C virus coinfection in Canada: challenges and opportunities for reducing preventable morbidity and mortality. Hiv Medicine. 14: 10-20. PMID 22639840 DOI: 10.1111/J.1468-1293.2012.01028.X |
0.224 |
|
| 2010 |
d'Arminio Monforte A, González L, Haberl A, Sherr L, Ssanyu-Sseruma W, Walmsley SL. Better mind the gap: addressing the shortage of HIV-positive women in clinical trials. Aids (London, England). 24: 1091-4. PMID 20386426 DOI: 10.1097/QAD.0b013e3283390db3 |
0.223 |
|
| 2011 |
Tan DH, Kaul R, Raboud JM, Walmsley SL. No impact of oral tenofovir disoproxil fumarate on herpes simplex virus shedding in HIV-infected adults. Aids (London, England). 25: 207-10. PMID 21150556 DOI: 10.1097/Qad.0B013E328341Ddf7 |
0.223 |
|
| 2016 |
Kim CJ, Walmsley SL, Raboud JM, Kovacs C, Coburn B, Rousseau R, Reinhard R, Rosenes R, Kaul R. Can Probiotics Reduce Inflammation and Enhance Gut Immune Health in People Living with HIV: Study Designs for the Probiotic Visbiome for Inflammation and Translocation (PROOV IT) Pilot Trials. Hiv Clinical Trials. 1-11. PMID 27267710 DOI: 10.1080/15284336.2016.1184827 |
0.222 |
|
| 2008 |
Walmsley S, Cheung AM, Fantus G, Gough K, Smaill F, Azad, Diong C, Raboud J. A prospective study of body fat redistribution, lipid, and glucose parameters in HIV-infected patients initiating combination antiretroviral therapy. Hiv Clinical Trials. 9: 314-23. PMID 18977720 DOI: 10.1310/Hct0905-314 |
0.222 |
|
| 2010 |
Cooper DA, Heera J, Goodrich J, Tawadrous M, Saag M, Dejesus E, Clumeck N, Walmsley S, Ting N, Coakley E, Reeves JD, Reyes-Teran G, Westby M, Van Der Ryst E, Ive P, et al. Maraviroc versus efavirenz, both in combination with zidovudine-lamivudine, for the treatment of antiretroviral-naive subjects with CCR5-tropic HIV-1 infection. The Journal of Infectious Diseases. 201: 803-13. PMID 20151839 DOI: 10.1086/650697 |
0.221 |
|
| 2015 |
Tan DH, Raboud JM, Szadkowski L, Yi TJ, Shannon B, Kaul R, Liles WC, Walmsley SL. Herpes simplex virus type 2 serostatus is not associated with inflammatory or metabolic markers in antiretroviral therapy-treated HIV. Aids Research and Human Retroviruses. 31: 276-81. PMID 25399537 DOI: 10.1089/Aid.2014.0183 |
0.221 |
|
| 2015 |
Brunet L, Moodie EE, Young J, Cox J, Hull M, Cooper C, Walmsley S, Martel-Laferrière V, Rachlis A, Klein MB. Progression of Liver Fibrosis and Modern Combination Antiretroviral Therapy Regimens in HIV-Hepatitis C-Coinfected Persons. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 26400998 DOI: 10.1093/Cid/Civ838 |
0.22 |
|
| 2012 |
Raboud J, Blitz S, Antoniou T, Loutfy M, Walmsley S. Recent immigrants show improved clinical outcomes at a tertiary care HIV clinic. The Canadian Journal of Infectious Diseases & Medical Microbiology = Journal Canadien Des Maladies Infectieuses Et De La Microbiologie MéDicale / Ammi Canada. 23: 9-14. PMID 23449134 DOI: 10.1155/2012/963474 |
0.219 |
|
| 2009 |
Walmsley S, Avihingsanon A, Slim J, Ward DJ, Ruxrungtham K, Brunetta J, Bredeek UF, Jayaweera D, Guittari CJ, Larson P, Schutz M, Raffi F. Gemini: A noninferiority study of saquinavir/ritonavir versus lopinavir/ritonavir as initial HIV-I therapy in adults Journal of Acquired Immune Deficiency Syndromes. 50: 367-374. PMID 19214123 DOI: 10.1097/Qai.0B013E318198A815 |
0.218 |
|
| 2012 |
Cooper C, Klein M, Walmsley S, Haase D, MacKinnon-Cameron D, Marty K, Li Y, Smith B, Halperin S, Law B, Scheifele D, Phac Cihr Influenza Research Network. High-level immunogenicity is achieved vaccine with adjuvanted pandemic H1N1(2009) and improved with booster dosing in a randomized trial of HIV-infected adults. Hiv Clinical Trials. 13: 23-32. PMID 22306585 DOI: 10.1310/hct1301-023 |
0.218 |
|
| 2013 |
Blitz S, Baxter J, Raboud J, Walmsley S, Rachlis A, Smaill F, Ferenczy A, Coutlée F, Hankins C, Money D. Evaluation of HIV and highly active antiretroviral therapy on the natural history of human papillomavirus infection and cervical cytopathologic findings in HIV-positive and high-risk HIV-negative women. The Journal of Infectious Diseases. 208: 454-62. PMID 23624362 DOI: 10.1093/Infdis/Jit181 |
0.218 |
|
| 2013 |
Loutfy MR, Sherr L, Sonnenberg-Schwan U, Walmsley SL, Johnson M, d'Arminio Monforte A. Caring for women living with HIV: gaps in the evidence. Journal of the International Aids Society. 16: 18509. PMID 24088395 DOI: 10.7448/IAS.16.1.18509 |
0.218 |
|
| 2007 |
Reynes J, Arastéh K, Clotet B, Cohen C, Cooper DA, Delfraissy JF, Eron JJ, Henry K, Katlama C, Kuritzkes DR, Lalezari JP, Lange J, Lazzarin A, Montaner JS, Nelson M, ... Walmsley SL, et al. TORO: ninety-six-week virologic and immunologic response and safety evaluation of enfuvirtide with an optimized background of antiretrovirals. Aids Patient Care and Stds. 21: 533-43. PMID 17711378 DOI: 10.1089/Apc.2006.0174 |
0.216 |
|
| 2014 |
Klein MB, Rollet-Kurhajec KC, Moodie EE, Yaphe S, Tyndall M, Walmsley S, Gill J, Martel-Laferriere V, Cooper C. Mortality in HIV-hepatitis C co-infected patients in Canada compared to the general Canadian population (2003-2013). Aids (London, England). 28: 1957-65. PMID 25259703 DOI: 10.1097/Qad.0000000000000377 |
0.216 |
|
| 2007 |
Walmsley SL, Cotte L, Rusconi S, Ward DJ, Hicks CB, Meier U, Valdez H, Boucher CA. Treatment response to ritonavir-boosted tipranavir versus ritonavir-boosted lopinavir in HIV-1 patients with higher lopinavir mutation scores. Aids (London, England). 21: 2245-8. PMID 18090054 DOI: 10.1097/QAD.0b013e3282ef6db7 |
0.214 |
|
| 2015 |
Rollet-Kurhajec KC, Moodie EE, Walmsley S, Cooper C, Pick N, Klein MB. Hepatic Fibrosis Progression in HIV-Hepatitis C Virus Co-Infection - The Effect of Sex on Risk of Significant Fibrosis Measured by Aspartate-to-Platelet Ratio Index. Plos One. 10: e0129868. PMID 26090666 DOI: 10.1371/Journal.Pone.0129868 |
0.214 |
|
| 2015 |
Cescon A, Patterson S, Davey C, Ding E, Raboud JM, Chan K, Loutfy MR, Cooper C, Burchell AN, Palmer AK, Tsoukas C, Machouf N, Klein MB, Rourke SB, Rachlis A, ... Walmsley S, et al. Late initiation of combination antiretroviral therapy in Canada: A call for a national public health strategy to improve engagement in HIV care Journal of the International Aids Society. 18. DOI: 10.7448/IAS.18.1.20024 |
0.213 |
|
| 2009 |
Bogoch I, Walmsley S. First-line regimen failure of antiretroviral therapy: A clinical and evidence-based approach Current Opinion in Hiv and Aids. 4: 493-498. PMID 20048716 DOI: 10.1097/Coh.0B013E328331B5E2 |
0.213 |
|
| 2016 |
Saeed S, Strumpf EC, Walmsley S, Rollet-Kurhajec K, Pick N, Martel-Laferriere V, Hull M, Gill MJ, Cox J, Cooper C, Klein MB. How generalizable are the results from trials of Direct Antiviral Agents to people coinfected with HIV/Hepatitis C virus in the real world? Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 26743093 DOI: 10.1093/Cid/Civ1222 |
0.212 |
|
| 2014 |
Hulgan T, Boger MS, Liao DH, McComsey GA, Wanke CA, Mangili A, Walmsley SL, McCreath H, Milne GL, Sanchez SC, Currier JS, Lake JE. Urinary eicosanoid metabolites in HIV-infected women with central obesity switching to raltegravir: an analysis from the women, integrase, and fat accumulation trial. Mediators of Inflammation. 2014: 803095. PMID 24991090 DOI: 10.1155/2014/803095 |
0.211 |
|
| 2010 |
Raboud J, Li M, Blitz S, D'Aquila A, Sterling S, Walmsley S. Factors associated with HIV-positive women carrying pregnancies to term. Journal of Obstetrics and Gynaecology Canada : Jogc = Journal D'ObstéTrique Et GynéCologie Du Canada : Jogc. 32: 756-62. PMID 21050507 DOI: 10.1016/S1701-2163(16)34616-3 |
0.21 |
|
| 2012 |
Loutfy M, Raboud J, Wong J, Yudin M, Diong C, Blitz S, Margolese S, Hart T, Ogilvie G, Masinde K, Tharao W, Linklater G, Salam K, Ongoiba F, Angel J, ... Walmsley S, et al. High prevalence of unintended pregnancies in HIV-positive women of reproductive age in Ontario, Canada: a retrospective study. Hiv Medicine. 13: 107-17. PMID 22103297 DOI: 10.1111/J.1468-1293.2011.00946.X |
0.205 |
|
| 2012 |
Powis JE, Raboud J, Ostrowski M, Loutfy MR, Kovacs C, Walmsley SL. The recombinant hepatitis B surface antigen vaccine in persons with HIV: is seroconversion sufficient for long-term protection? The Journal of Infectious Diseases. 205: 1534-8. PMID 22448009 DOI: 10.1093/Infdis/Jis243 |
0.2 |
|
| 2014 |
Klein MB, Lee T, Brouillette MJ, Sheehan NL, Walmsley S, Wong DK, Conway B, Hull M, Cooper C, Haidar S, Vezina S, Annable L, Young S, Zubyk W, Singer J. Citalopram for the prevention of depression and its consequences in HIV-hepatitis C coinfected individuals initiating pegylated interferon/ribavirin therapy: a multicenter randomized double-blind placebo-controlled trial. Hiv Clinical Trials. 15: 161-75. PMID 25143025 DOI: 10.1310/Hct1504-161 |
0.198 |
|
| 2010 |
Raboud JM, Diong C, Carr A, Grinspoon S, Mulligan K, Sutinen J, Rozenbaum W, Cavalcanti RB, Wand H, Costagliola D, Walmsley S. A meta-analysis of six placebo-controlled trials of thiazolidinedione therapy for HIV lipoatrophy. Hiv Clinical Trials. 11: 39-50. PMID 20400410 DOI: 10.1310/Hct1101-39 |
0.198 |
|
| 2007 |
Loutfy MR, Harris M, Raboud JM, Antoniou T, Kovacs C, Shen S, Dufresne S, Smaill F, Rouleau D, Rachlis A, Gough K, Lalonde R, Tsoukas C, Trottier B, Walmsley SL, et al. A large prospective study assessing injection site reactions, quality of life and preference in patients using the Biojector ® vs standard needles for enfuvirtide administration * Hiv Medicine. 8: 427-432. PMID 17760734 DOI: 10.1111/J.1468-1293.2007.00489.X |
0.196 |
|
| 2011 |
Andany N, Raboud JM, Walmsley S, Diong C, Rourke SB, Rueda S, Rachlis A, Wobeser W, Macarthur RD, Binder L, Rosenes R, Loutfy MR. Ethnicity and gender differences in lipodystrophy of HIV-positive individuals taking antiretroviral therapy in Ontario, Canada. Hiv Clinical Trials. 12: 89-103. PMID 21498152 DOI: 10.1310/Hct1202-89 |
0.194 |
|
| 2016 |
Papp E, Balogun K, Banko N, Mohammadi H, Loutfy M, Yudin MH, Shah R, MacGillivray J, Murphy KE, Walmsley SL, Silverman M, Serghides L. Low prolactin and high 20alpha-hydroxysteroid dehydrogenase contribute to lower progesterone in HIV-infected protease inhibitor-cART exposed pregnant women. The Journal of Infectious Diseases. PMID 26740274 DOI: 10.1093/Infdis/Jiw004 |
0.193 |
|
| 2015 |
Yeung MW, Young J, Moodie E, Rollet-Kurhajec KC, Schwartzman K, Greenaway C, Cooper C, Cox J, Gill J, Hull M, Walmsley S, Klein MB. Changes in quality of life, healthcare use, and substance use in HIV/hepatitis C coinfected patients after hepatitis C therapy: A prospective cohort study Hiv Clinical Trials. 16: 100-110. DOI: 10.13039/501100000024 |
0.191 |
|
| 2013 |
Raboud J, Su D, Burchell AN, Gardner S, Walmsley S, Bayoumi AM, Blitz S, Cooper C, Salit I, Cohen J, Rourke SB, Loutfy MR. Representativeness of an HIV cohort of the sites from which it is recruiting: results from the Ontario HIV Treatment Network (OHTN) cohort study. Bmc Medical Research Methodology. 13: 31. PMID 23496868 DOI: 10.1186/1471-2288-13-31 |
0.189 |
|
| 2014 |
Kennedy VL, Serghides L, Raboud JM, Su D, Blitz S, Hart TA, Walmsley SL, Angel JB, Smaill FM, Ralph ED, Tharao WE, Loutfy MR. The importance of motherhood in HIV-positive women of reproductive age in Ontario, Canada. Aids Care. 26: 777-84. PMID 24206065 DOI: 10.1080/09540121.2013.855295 |
0.188 |
|
| 2013 |
Beauchamp E, Rollet K, Walmsley S, Wong DK, Cooper C, Klein MB. Missed opportunities for hepatocellular carcinoma screening in an HIV/hepatitis C virus-coinfected cohort. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 57: 1339-42. PMID 23899675 DOI: 10.1093/Cid/Cit491 |
0.188 |
|
| 2012 |
Barrett L, Walmsley S. CMV retinopathy in the antiretroviral therapy era: prevention, diagnosis, and management. Current Infectious Disease Reports. 14: 435-44. PMID 22688820 DOI: 10.1007/S11908-012-0269-1 |
0.18 |
|
| 2013 |
Brunet L, Moodie EE, Rollet K, Cooper C, Walmsley S, Potter M, Klein MB. Marijuana smoking does not accelerate progression of liver disease in HIV-hepatitis C coinfection: a longitudinal cohort analysis. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 57: 663-70. PMID 23811492 DOI: 10.1093/Cid/Cit378 |
0.178 |
|
| 2015 |
Yeung MW, Young J, Moodie E, Rollet-Kurhajec KC, Schwartzman K, Greenaway C, Cooper C, Cox J, Gill J, Hull M, Walmsley S, Klein MB. Changes in quality of life, healthcare use, and substance use in HIV/hepatitis C coinfected patients after hepatitis C therapy: a prospective cohort study. Hiv Clinical Trials. 16: 100-10. PMID 25972048 DOI: 10.1179/501100000024 |
0.178 |
|
| 2014 |
Yam KK, Gipson E, Klein M, Walmsley S, Haase D, Halperin S, Scheifele D, Ward BJ, Cooper C. High level antibody avidity is achieved in HIV-seropositive recipients of an inactivated split adjuvanted (AS03A) influenza vaccine. Journal of Clinical Immunology. 34: 655-62. PMID 24824648 DOI: 10.1007/S10875-014-0054-Z |
0.177 |
|
| 2016 |
Costiniuk CT, Brunet L, Rollet-Kurhajec KC, Cooper CL, Walmsley SL, Gill MJ, Martel-Laferriere V, Klein MB. Tobacco Smoking Is Not Associated With Accelerated Liver Disease in Human Immunodeficiency Virus-Hepatitis C Coinfection: A Longitudinal Cohort Analysis. Open Forum Infectious Diseases. 3: ofw050. PMID 27047987 DOI: 10.1093/Ofid/Ofw050 |
0.175 |
|
| 2013 |
Hopkinson N, Wallis C, Higgins B, Gaduzo S, Sherrington R, Keilty S, Stern M, Britton J, Bush A, Moxham J, Sylvester K, Griffiths V, Sutherland T, Crossingham I, Raju R, ... ... Walmsley S, et al. Children must be protected from the tobacco industry's marketing tactics. Bmj (Clinical Research Ed.). 347: f7358. PMID 24324220 |
0.174 |
|
| 2013 |
Tseng A, Szadkowski L, Walmsley S, Salit I, Raboud J. Association of age with polypharmacy and risk of drug interactions with antiretroviral medications in HIV-positive patients. The Annals of Pharmacotherapy. 47: 1429-39. PMID 24285760 DOI: 10.1177/1060028013504075 |
0.172 |
|
| 2016 |
Alvarez E, Belloso WH, Boyd MA, Inkaya AÇ, Hsieh E, Kambugu A, Kaminski G, Martinez E, Stellbrink HJ, Walmsley S, Brown TT, Mallon PW. Which HIV patients should be screened for osteoporosis: an international perspective. Current Opinion in Hiv and Aids. PMID 26895510 DOI: 10.1097/Coh.0000000000000269 |
0.172 |
|
| 2012 |
Avihingsanon A, Ruxrungtham K, Katner H, Jean Guittari C, Walmsley S. Impact of baseline virologic, immunologic, and demographic characteristics on virologic responses in the Gemini study. Hiv Clinical Trials. 13: 111-7. PMID 22510358 DOI: 10.1310/Hct1302-111 |
0.169 |
|
| 2010 |
Loutfy MR, Genebat M, Moore D, Raboud J, Chan K, Antoniou T, Milan D, Shen A, Klein MB, Cooper C, Machouf N, Rourke SB, Rachlis A, Tsoukas C, Montaner JS, ... Walmsley SL, et al. A CD4+ cell count <200 cells per cubic millimeter at 2 years after initiation of combination antiretroviral therapy is associated with increased mortality in HIV-infected individuals with viral suppression. Journal of Acquired Immune Deficiency Syndromes (1999). 55: 451-9. PMID 21105259 DOI: 10.1097/Qai.0B013E3181Ec28Ff |
0.166 |
|
| 2008 |
Wright D, Rodriguez A, Godofsky E, Walmsley S, Labriola-Tompkins E, Donatacci L, Shikhman A, Tucker E, Chiu YY, Chung J, Rowell L, Demasi R, Graham N, Salgo M. Efficacy and safety of 48 weeks of enfuvirtide 180 mg once-daily dosing versus 90 mg twice-daily dosing in HIV-infected patients. Hiv Clinical Trials. 9: 73-82. PMID 18474492 DOI: 10.1310/Hct0902-73 |
0.165 |
|
| 2013 |
Young J, Potter M, Cox J, Cooper C, Gill J, Hull M, Walmsley S, Klein MB. Variation between Canadian centres in the uptake of treatment for hepatitis C by patients coinfected with HIV: a prospective cohort study. Cmaj Open. 1: E106-14. PMID 25077109 DOI: 10.9778/cmajo.20130009 |
0.164 |
|
| 2016 |
Rossi C, Cox J, Cooper C, Martel-Laferrière V, Walmsley S, Gill J, Sapir-Pichhadze R, Moodie EE, Klein MB. Frequent injection cocaine use increases the risk of renal impairment among hepatitis C and HIV co-infected patients. Aids (London, England). PMID 26859371 DOI: 10.1097/Qad.0000000000001060 |
0.163 |
|
| 2011 |
Cooper C, Thorne A, Klein M, Conway B, Boivin G, Haase D, Shafran S, Zubyk W, Singer J, Halperin S, Walmsley S. Immunogenicity is not improved by increased antigen dose or booster dosing of seasonal influenza vaccine in a randomized trial of HIV infected adults. Plos One. 6: e17758. PMID 21512577 DOI: 10.1371/Journal.Pone.0017758 |
0.163 |
|
| 2008 |
Walmsley SL, Katlama C, Lazzarin A, Arestéh K, Pierone G, Blick G, Johnson M, Meier U, MacGregor TR, Leith JG. Pharmacokinetics, safety, and efficacy of tipranavir boosted with ritonavir alone or in combination with other boosted protease inhibitors as part of optimized combination antiretroviral therapy in highly treatment-experienced patients (BI study 1182.51) Journal of Acquired Immune Deficiency Syndromes. 47: 429-440. PMID 18176328 DOI: 10.1097/QAI.0b013e318160a529 |
0.163 |
|
| 2007 |
Prior J, Burdge D, Maan E, Milner R, Hankins C, Klein M, Walmsley S. Fragility fractures and bone mineral density in HIV positive women: a case-control population-based study. Osteoporosis International : a Journal Established as Result of Cooperation Between the European Foundation For Osteoporosis and the National Osteoporosis Foundation of the Usa. 18: 1345-53. PMID 17665239 DOI: 10.1007/S00198-007-0428-7 |
0.161 |
|
| 2016 |
Llibre JM, Walmsley S, Gatell JM. Backbones versus core agents in initial ART regimens: one game, two players. The Journal of Antimicrobial Chemotherapy. PMID 26747092 DOI: 10.1093/Jac/Dkv429 |
0.157 |
|
| 2015 |
Lake JE, McComsey GA, Hulgan T, Wanke CA, Mangili A, Walmsley SL, Currier JS. Switch to Raltegravir From Protease Inhibitor or Nonnucleoside Reverse-Transcriptase Inhibitor Does not Reduce Visceral Fat In Human Immunodeficiency Virus-Infected Women With Central Adiposity. Open Forum Infectious Diseases. 2: ofv059. PMID 26380350 DOI: 10.1093/ofid/ofv059 |
0.157 |
|
| 2013 |
Klein MB, Rollet KC, Hull M, Cooper C, Walmsley S, Conway B, Pick N. Who needs direct-acting antivirals for HCV? Challenges faced in advancing HCV therapy for HIV-HCV-coinfected individuals. Antiviral Therapy. 18: 717-21. PMID 23211632 DOI: 10.3851/Imp2484 |
0.157 |
|
| 2012 |
Hull MW, Rollet K, Moodie EE, Walmsley S, Cox J, Potter M, Cooper C, Pick N, Saeed S, Klein MB. Insulin resistance is associated with progression to hepatic fibrosis in a cohort of HIV/hepatitis C virus-coinfected patients. Aids (London, England). 26: 1789-94. PMID 22739388 DOI: 10.1097/Qad.0B013E32835612Ce |
0.156 |
|
| 2009 |
Walmsley S, Wilkin T, Moyle G. Antiretroviral rounds. Too many options? Aids Clinical Care. 21: 13-15. PMID 19253449 |
0.147 |
|
| 2007 |
Raboud J, Lesosky M, Sterling S, Phillips E, Walmsley S, Bayoumi A. An estimate of the proportion of symptoms reported in self-administered questionnaires that are captured as adverse drug events in an observational database. Hiv Clinical Trials. 8: 311-9. PMID 17956832 DOI: 10.1310/Hct0805-311 |
0.123 |
|
| 2020 |
McClymont E, Lee M, Raboud J, Coutlée F, Walmsley S, Lipsky N, Loutfy M, Trottier S, Smaill F, Klein MB, Harris M, Cohen J, Yudin MH, Wobeser W, Money D, et al. Prevalent and persistent oncogenic HPV types in a cohort of women living with HIV prior to HPV vaccination. International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics. PMID 32342504 DOI: 10.1002/Ijgo.13185 |
0.12 |
|
| 2015 |
Brunet L, Moodie E, Cox J, Gill J, Cooper C, Walmsley S, Rachlis A, Hull M, Klein MB. Opioid use and risk of liver fibrosis in HIV/hepatitis C virus-coinfected patients in Canada. Hiv Medicine. PMID 26140381 DOI: 10.1111/Hiv.12279 |
0.12 |
|
| 2014 |
Kis O, Walmsley SL, Bendayan R. In Vitro and In Situ evaluation of pH-dependence of atazanavir intestinal permeability and interactions with acid-reducing agents. Pharmaceutical Research. 31: 2404-19. PMID 24595498 DOI: 10.1007/s11095-014-1336-0 |
0.12 |
|
| 2007 |
Loutfy MR, Raboud JM, Montaner JSG, Antoniou T, Wynhoven B, Smaill F, Rouleau D, Gill J, Schlech W, Brumme ZL, Mo T, Gough K, Rachlis A, Harrigan PR, Walmsley SL. Assay of HIV gp41 amino acid sequence to identify baseline variation and mutation development in patients with virologic failure on enfuvirtide Antiviral Research. 75: 58-63. PMID 17196268 DOI: 10.1016/j.antiviral.2006.11.011 |
0.119 |
|
| 2011 |
Raboud J, Li M, Walmsley S, Cooper C, Blitz S, Bayoumi AM, Rourke S, Rueda S, Rachlis A, Mittmann N, Smieja M, Collins E, Loutfy MR. Once daily dosing improves adherence to antiretroviral therapy. Aids and Behavior. 15: 1397-409. PMID 20878227 DOI: 10.1007/S10461-010-9818-5 |
0.116 |
|
| 2013 |
Kis O, Zastre JA, Hoque MT, Walmsley SL, Bendayan R. Role of drug efflux and uptake transporters in atazanavir intestinal permeability and drug-drug interactions. Pharmaceutical Research. 30: 1050-64. PMID 23224979 DOI: 10.1007/s11095-012-0942-y |
0.113 |
|
| 2016 |
Wollina U, Tirant M, Bayer P, Coburn M, Anderson P, Donnelly B, Kennedy T, Gaibor J, Arora M, Clews L, Walmsley S, Hercogovấ J, Fioranelli M, Gianfaldoni S, Chokoeva AA, et al. Successful treatment of mild to moderate acne vulgaris with Dr Michaels® (also branded as Zitinex®) topical products family: a clinical trial. Journal of Biological Regulators and Homeostatic Agents. 30: 49-54. PMID 27498658 |
0.11 |
|
| 2015 |
Moqueet N, Infante-Rivard C, Platt RW, Young J, Cooper C, Hull M, Walmsley S, Klein MB. Favourable IFNL3 genotypes are associated with spontaneous clearance and are differentially distributed in Aboriginals in Canadian HIV-hepatitis C co-infected individuals. International Journal of Molecular Sciences. 16: 6496-512. PMID 25803108 DOI: 10.3390/Ijms16036496 |
0.107 |
|
| 2014 |
Robertson AL, Holmes GR, Bojarczuk AN, Burgon J, Loynes CA, Chimen M, Sawtell AK, Hamza B, Willson J, Walmsley SR, Anderson SR, Coles MC, Farrow SN, Solari R, Jones S, et al. A zebrafish compound screen reveals modulation of neutrophil reverse migration as an anti-inflammatory mechanism. Science Translational Medicine. 6: 225ra29. PMID 24574340 DOI: 10.1126/Scitranslmed.3007672 |
0.102 |
|
| 2016 |
Maliakkal A, Walmsley S, Tseng A. Critical Review: Review of the Efficacy, Safety, and Pharmacokinetics of Raltegravir in Pregnancy. Journal of Acquired Immune Deficiency Syndromes (1999). 72: 153-61. PMID 27183177 DOI: 10.1097/Qai.0000000000000932 |
0.101 |
|
| 2009 |
Walmsley SR, Chilvers ER, Whyte MKB. Hypoxia. Hypoxia, hypoxia inducible factor and myeloid cell function Arthritis Research & Therapy. 11: 219. PMID 19435530 |
0.1 |
|
| 2014 |
Arbuckle R, Humphrey L, Abraham L, Dennerstein L, Simon JA, Mirkin S, Bonner N, Walmsley S, Tatlock S, Symonds T. Qualitative cross-cultural exploration of vaginal bleeding/spotting symptoms and impacts associated with hormone therapy in post-menopausal women to inform the development of new patient-reported measurement tools. Maturitas. 78: 219-27. PMID 24856282 DOI: 10.1016/j.maturitas.2014.04.019 |
0.099 |
|
| 2013 |
Elks PM, Brizee S, van der Vaart M, Walmsley SR, van Eeden FJ, Renshaw SA, Meijer AH. Hypoxia inducible factor signaling modulates susceptibility to mycobacterial infection via a nitric oxide dependent mechanism. Plos Pathogens. 9: e1003789. PMID 24367256 DOI: 10.1371/journal.ppat.1003789 |
0.099 |
|
| 2013 |
Thompson AA, Binham J, Plant T, Whyte MK, Walmsley SR. Hypoxia, the HIF pathway and neutrophilic inflammatory responses. Biological Chemistry. 394: 471-7. PMID 23324383 DOI: 10.1515/hsz-2012-0335 |
0.095 |
|
| 2010 |
Webster SJ, Daigneault M, Bewley MA, Preston JA, Marriott HM, Walmsley SR, Read RC, Whyte MK, Dockrell DH. Distinct cell death programs in monocytes regulate innate responses following challenge with common causes of invasive bacterial disease. Journal of Immunology (Baltimore, Md. : 1950). 185: 2968-79. PMID 20656927 DOI: 10.4049/jimmunol.1000805 |
0.095 |
|
| 2008 |
Walmsley S. Combining protease inhibitors with new drug classes in treatment- experienced patients Current Opinion in Hiv and Aids. 3: 647-652. DOI: 10.1097/COH.0b013e3283136c9b |
0.094 |
|
| 2011 |
Walmsley SR, Chilvers ER, Thompson AA, Vaughan K, Marriott HM, Parker LC, Shaw G, Parmar S, Schneider M, Sabroe I, Dockrell DH, Milo M, Taylor CT, Johnson RS, Pugh CW, et al. Prolyl hydroxylase 3 (PHD3) is essential for hypoxic regulation of neutrophilic inflammation in humans and mice. The Journal of Clinical Investigation. 121: 1053-63. PMID 21317538 DOI: 10.1172/Jci43273 |
0.09 |
|
| 2015 |
Elks PM, Renshaw SA, Meijer AH, Walmsley SR, van Eeden FJ. Exploring the HIFs, buts and maybes of hypoxia signalling in disease: lessons from zebrafish models. Disease Models & Mechanisms. 8: 1349-60. PMID 26512123 DOI: 10.1242/dmm.021865 |
0.089 |
|
| 2006 |
Kaul P, Walmsley S, Mulcahy F. Antiretroviral rounds. A patient with multiple resistance mutations and a history of nonadherence Aids Clinical Care. 18: 110-111. PMID 17228445 |
0.086 |
|
| 2014 |
Thompson AA, Elks PM, Marriott HM, Eamsamarng S, Higgins KR, Lewis A, Williams L, Parmar S, Shaw G, McGrath EE, Formenti F, Van Eeden FJ, Kinnula VL, Pugh CW, Sabroe I, ... ... Walmsley SR, et al. Hypoxia-inducible factor 2α regulates key neutrophil functions in humans, mice, and zebrafish. Blood. 123: 366-76. PMID 24196071 DOI: 10.1182/Blood-2013-05-500207 |
0.086 |
|
| 2014 |
Whyte MK, Walmsley SR. The regulation of pulmonary inflammation by the hypoxia-inducible factor-hydroxylase oxygen-sensing pathway. Annals of the American Thoracic Society. 11: S271-6. PMID 25525731 DOI: 10.1513/AnnalsATS.201403-108AW |
0.083 |
|
| 2007 |
Kumar D, Humar A, Plevneshi A, Green K, Prasad GVR, Siegal D, McGeer A, Da Camara P, Downey J, Devlin HR, Dick H, Gaid IN, Kitai I, Garrod P, Rau N, ... ... Walmsley S, et al. Invasive pneumococcal disease in solid organ transplant recipients - 10-Year prospective population surveillance American Journal of Transplantation. 7: 1209-1214. PMID 17286615 DOI: 10.1111/J.1600-6143.2006.01705.X |
0.082 |
|
| 2020 |
Boysen G, Arora R, Degner A, Vevang KR, Chao C, Rodriguez F, Walmsley SJ, Erber L, Tretyakova NY, Peterson LA. Effects of Genotype on the Detoxification of 1,3-Butadiene Derived Diepoxide and Formation of Promutagenic DNA-DNA Cross-Links in Human Hapmap Cell Lines. Chemical Research in Toxicology. PMID 33381973 DOI: 10.1021/acs.chemrestox.0c00376 |
0.082 |
|
| 2008 |
Walmsley SR, McGovern NN, Whyte MKB, Chilvers ER. The HIF/VHL pathway: From oxygen sensing to innate immunity American Journal of Respiratory Cell and Molecular Biology. 38: 251-255. PMID 17932373 DOI: 10.1165/rcmb.2007-0331TR |
0.081 |
|
| 2011 |
McGovern NN, Cowburn AS, Porter L, Walmsley SR, Summers C, Thompson AA, Anwar S, Willcocks LC, Whyte MK, Condliffe AM, Chilvers ER. Hypoxia selectively inhibits respiratory burst activity and killing of Staphylococcus aureus in human neutrophils. Journal of Immunology (Baltimore, Md. : 1950). 186: 453-63. PMID 21135168 DOI: 10.4049/jimmunol.1002213 |
0.08 |
|
| 2013 |
Basran A, Jabeen M, Bingle L, Stokes CA, Dockrell DH, Whyte MK, Walmsley SR, Higgins KR, Vogel SN, Wilson HL, Prince LR, Prestwich EC, Sabroe RA, Parker LC, Sabroe I. Roles of neutrophils in the regulation of the extent of human inflammation through delivery of IL-1 and clearance of chemokines. Journal of Leukocyte Biology. 93: 7-19. PMID 22904343 DOI: 10.1189/Jlb.0512250 |
0.08 |
|
| 2015 |
Finisguerra V, Di Conza G, Di Matteo M, Serneels J, Costa S, Thompson AA, Wauters E, Walmsley S, Prenen H, Granot Z, Casazza A, Mazzone M. MET is required for the recruitment of anti-tumoural neutrophils. Nature. 522: 349-53. PMID 25985180 DOI: 10.1038/nature14407 |
0.079 |
|
| 2011 |
Elks PM, van Eeden FJ, Dixon G, Wang X, Reyes-Aldasoro CC, Ingham PW, Whyte MK, Walmsley SR, Renshaw SA. Activation of hypoxia-inducible factor-1α (Hif-1α) delays inflammation resolution by reducing neutrophil apoptosis and reverse migration in a zebrafish inflammation model. Blood. 118: 712-22. PMID 21555741 DOI: 10.1182/blood-2010-12-324186 |
0.079 |
|
| 2009 |
Plevneshi A, Svoboda T, Armstrong I, Tyrrell G, Miranda A, Green K, Low D, McGeer A, Chen D, Davis I, Kitai I, Devila E, Devlin HR, Muller M, Dick H, ... ... Walmsley S, et al. Population-based surveillance for invasive pneumococcal disease in homeless adults in Toronto Plos One. 4. PMID 19787070 DOI: 10.1371/Journal.Pone.0007255 |
0.078 |
|
| 2012 |
Santhakumar K, Judson EC, Elks PM, McKee S, Elworthy S, van Rooijen E, Walmsley SS, Renshaw SA, Cross SS, van Eeden FJ. A zebrafish model to study and therapeutically manipulate hypoxia signaling in tumorigenesis. Cancer Research. 72: 4017-27. PMID 22665266 DOI: 10.1158/0008-5472.CAN-11-3148 |
0.078 |
|
| 2021 |
Bellamri M, Walmsley SJ, Turesky RJ. Metabolism and biomarkers of heterocyclic aromatic amines in humans. Genes and Environment : the Official Journal of the Japanese Environmental Mutagen Society. 43: 29. PMID 34271992 DOI: 10.1186/s41021-021-00200-7 |
0.077 |
|
| 2012 |
Kiss J, Mollenhauer M, Walmsley SR, Kirchberg J, Radhakrishnan P, Niemietz T, Dudda J, Steinert G, Whyte MK, Carmeliet P, Mazzone M, Weitz J, Schneider M. Loss of the oxygen sensor PHD3 enhances the innate immune response to abdominal sepsis. Journal of Immunology (Baltimore, Md. : 1950). 189: 1955-65. PMID 22786772 DOI: 10.4049/jimmunol.1103471 |
0.075 |
|
| 2008 |
Prince LR, Bianchi SM, Vaughan KM, Bewley MA, Marriott HM, Walmsley SR, Taylor GW, Buttle DJ, Sabroe I, Dockrell DH, Whyte MKB. Subversion of a lysosomal pathway regulating neutrophil apoptosis by a major bacterial toxin, pyocyanin Journal of Immunology. 180: 3502-3511. PMID 18292577 |
0.075 |
|
| 2012 |
Juss JK, Hayhoe RP, Owen CE, Bruce I, Walmsley SR, Cowburn AS, Kulkarni S, Boyle KB, Stephens L, Hawkins PT, Chilvers ER, Condliffe AM. Functional redundancy of class I phosphoinositide 3-kinase (PI3K) isoforms in signaling growth factor-mediated human neutrophil survival. Plos One. 7: e45933. PMID 23029326 DOI: 10.1371/journal.pone.0045933 |
0.074 |
|
| 2013 |
Luong le A, Fragiadaki M, Smith J, Boyle J, Lutz J, Dean JL, Harten S, Ashcroft M, Walmsley SR, Haskard DO, Maxwell PH, Walczak H, Pusey C, Evans PC. Cezanne regulates inflammatory responses to hypoxia in endothelial cells by targeting TRAF6 for deubiquitination. Circulation Research. 112: 1583-91. PMID 23564640 DOI: 10.1161/Circresaha.111.300119 |
0.072 |
|
| 2019 |
Reisdorph NA, Walmsley S, Reisdorph R. A Perspective and Framework for Developing Sample Type Specific Databases for LC/MS-Based Clinical Metabolomics. Metabolites. 10. PMID 31877765 DOI: 10.3390/Metabo10010008 |
0.071 |
|
| 2012 |
Marriott HM, Daigneault M, Thompson AA, Walmsley SR, Gill SK, Witcher DR, Wroblewski VJ, Hellewell PG, Whyte MK, Dockrell DH. A decoy receptor 3 analogue reduces localised defects in phagocyte function in pneumococcal pneumonia. Thorax. 67: 985-92. PMID 22735687 DOI: 10.1136/thoraxjnl-2012-201591 |
0.07 |
|
| 2010 |
Walmsley S, Williams AE, Ravey M, Graham A. The rheumatoid foot: a systematic literature review of patient-reported outcome measures. Journal of Foot and Ankle Research. 3: 12. PMID 20618927 DOI: 10.1186/1757-1146-3-12 |
0.067 |
|
| 2015 |
Abraham L, Humphrey L, Arbuckle R, Dennerstein L, Simon JA, Mirkin S, Bonner N, Walmsley S, Tatlock S, Symonds T. Qualitative cross-cultural exploration of breast symptoms and impacts associated with hormonal treatments for menopausal symptoms to inform the development of new patient-reported measurement tools. Maturitas. 80: 273-81. PMID 25542407 DOI: 10.1016/j.maturitas.2014.11.019 |
0.064 |
|
| 2007 |
Daneman N, Green KA, Low DE, Simor AE, Willey B, Schwartz B, Toye B, Jessamine P, Tyrrell GJ, Krajden S, Ramage L, Rose D, Schertzberg R, Bragg D, McGeer A, ... ... Walmsley S, et al. Surveillance for hospital outbreaks of invasive group A streptococcal infections in Ontario, Canada, 1992 to 2000 Annals of Internal Medicine. 147: 234-241. PMID 17709757 DOI: 10.7326/0003-4819-147-4-200708210-00004 |
0.064 |
|
| 2013 |
Tannahill GM, Curtis AM, Adamik J, Palsson-McDermott EM, McGettrick AF, Goel G, Frezza C, Bernard NJ, Kelly B, Foley NH, Zheng L, Gardet A, Tong Z, Jany SS, Corr SC, ... ... Walmsley S, et al. Succinate is an inflammatory signal that induces IL-1β through HIF-1α. Nature. 496: 238-42. PMID 23535595 DOI: 10.1038/Nature11986 |
0.063 |
|
| 2012 |
Walmsley S, Ravey M, Graham A, Teh LS, Williams AE. Development of a patient-reported outcome measure for the foot affected by rheumatoid arthritis. Journal of Clinical Epidemiology. 65: 413-22. PMID 22360989 DOI: 10.1016/j.jclinepi.2011.11.005 |
0.062 |
|
| 2019 |
Lim J, Yu D, Kuo HC, Choi H, Walmsley S. Truncated rank correlation (TRC) as a robust measure of test-retest reliability in mass spectrometry data. Statistical Applications in Genetics and Molecular Biology. PMID 31145698 DOI: 10.1515/Sagmb-2018-0056 |
0.062 |
|
| 2014 |
Kuster SP, Rudnick W, Shigayeva A, Green K, Baqi M, Gold WL, Lovinsky R, Muller MP, Powis JE, Rau N, Simor AE, Walmsley SL, Low DE, McGeer A. Previous antibiotic exposure and antimicrobial resistance in invasive pneumococcal disease: results from prospective surveillance. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 59: 944-52. PMID 24973312 DOI: 10.1093/cid/ciu497 |
0.061 |
|
| 2012 |
McGrath EE, Lawrie A, Marriott HM, Mercer P, Cross SS, Arnold N, Singleton V, Thompson AA, Walmsley SR, Renshaw SA, Sabroe I, Chambers RC, Dockrell DH, Whyte MK. Deficiency of tumour necrosis factor-related apoptosis-inducing ligand exacerbates lung injury and fibrosis. Thorax. 67: 796-803. PMID 22496351 DOI: 10.1136/thoraxjnl-2011-200863 |
0.06 |
|
| 2010 |
Walmsley SJ, Broeckling C, Hess A, Prenni J, Curthoys NP. Proteomic analysis of brush-border membrane vesicles isolated from purified proximal convoluted tubules. American Journal of Physiology. Renal Physiology. 298: F1323-31. PMID 20219825 DOI: 10.1152/Ajprenal.00711.2009 |
0.059 |
|
| 2015 |
Shigayeva A, Rudnick W, Green K, Chen DK, Demczuk W, Gold WL, Johnstone J, Kitai I, Krajden S, Lovinsky R, Muller M, Powis J, Rau N, Walmsley S, Tyrrell G, et al. Invasive Pneumococcal Disease Among Immunocompromised Persons: Implications for Vaccination Programs. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 26354970 DOI: 10.1093/Cid/Civ803 |
0.057 |
|
| 2018 |
Walmsley S, Cruickshank-Quinn C, Quinn K, Zhang X, Petrache I, Bowler RP, Reisdorph R, Reisdorph N. A prototypic small molecule database for bronchoalveolar lavage-based metabolomics. Scientific Data. 5: 180060. PMID 29664467 DOI: 10.1038/Sdata.2018.60 |
0.056 |
|
| 2010 |
Lenné MG, Dietze PM, Triggs TJ, Walmsley S, Murphy B, Redman JR. The effects of cannabis and alcohol on simulated arterial driving: Influences of driving experience and task demand. Accident; Analysis and Prevention. 42: 859-66. PMID 20380913 DOI: 10.1016/J.Aap.2009.04.021 |
0.053 |
|
| 2012 |
Walmsley SJ, Freund DM, Curthoys NP. Proteomic profiling of the effect of metabolic acidosis on the apical membrane of the proximal convoluted tubule. American Journal of Physiology. Renal Physiology. 302: F1465-77. PMID 22357915 DOI: 10.1152/Ajprenal.00390.2011 |
0.053 |
|
| 2014 |
Walmsley SR, Whyte MK. Neutrophil energetics and oxygen sensing. Blood. 123: 2753-4. PMID 24786455 DOI: 10.1182/blood-2014-03-560409 |
0.051 |
|
| 2019 |
Walmsley SJ, Guo J, Wang J, Villalta PW, Turesky RJ. Methods and Challenges for Computational Data Analysis for DNA Adductomics. Chemical Research in Toxicology. PMID 31549505 DOI: 10.1021/Acs.Chemrestox.9B00196 |
0.05 |
|
| 2013 |
Walmsley SJ, Rudnick PA, Liang Y, Dong Q, Stein SE, Nesvizhskii AI. Comprehensive analysis of protein digestion using six trypsins reveals the origin of trypsin as a significant source of variability in proteomics. Journal of Proteome Research. 12: 5666-80. PMID 24116745 DOI: 10.1021/Pr400611H |
0.049 |
|
| 2021 |
Walmsley SJ, Guo J, Murugan P, Weight CJ, Wang J, Villalta PW, Turesky RJ. Comprehensive Analysis of DNA Adducts Using Data-Independent wSIM/MS Acquisition and wSIM-City. Analytical Chemistry. PMID 33844920 DOI: 10.1021/acs.analchem.1c00362 |
0.047 |
|
| 2007 |
Tansey CM, Louie M, Loeb M, Gold WL, Muller MP, de Jager J, Cameron JI, Tomlinson G, Mazzulli T, Walmsley SL, Rachlis AR, Mederski BD, Silverman M, Shainhouse Z, Ephtimios IE, et al. One-year outcomes and health care utilization in survivors of severe acute respiratory syndrome. Archives of Internal Medicine. 167: 1312-20. PMID 17592106 DOI: 10.1001/Archinte.167.12.1312 |
0.047 |
|
| 2020 |
Chen H, Cui Z, Hejazi L, Yao L, Walmsley SJ, Rizzo CJ, Turesky RJ. Kinetics of DNA Adducts and Abasic Site Formation in Tissues of Mice Treated with a Nitrogen Mustard. Chemical Research in Toxicology. PMID 32174110 DOI: 10.1021/Acs.Chemrestox.0C00012 |
0.047 |
|
| 2013 |
Walmsley S, Osmotherly PG, Walker CJ, Rivett DA. Power Doppler ultrasonography in the early diagnosis of primary/idiopathic adhesive capsulitis: an exploratory study. Journal of Manipulative and Physiological Therapeutics. 36: 428-35. PMID 23830711 DOI: 10.1016/j.jmpt.2013.05.024 |
0.046 |
|
| 2007 |
Walmsley SA, Leslie RW, Sauer WHH. Managing South Africa's trawl bycatch Ices Journal of Marine Science. 64: 405-412. DOI: 10.1093/icesjms/fsl022 |
0.046 |
|
| 2017 |
Zhang X, Kew K, Reisdorph R, Sartain M, Powell R, Armstrong ML, Quinn K, Cruickshank-Quinn C, Walmsley S, Bokatzian SS, Darland E, Rain M, Imatani K, Reisdorph N. Performance of a High-Pressure Liquid Chromatography-Ion Mobility-Mass Spectrometry System for Metabolic Profiling. Analytical Chemistry. PMID 28528542 DOI: 10.1021/Acs.Analchem.6B04628 |
0.045 |
|
| 2007 |
Walmsley S. The clinical cost of delays in switching therapy | Coût clinique des retards dans le changement de traitement Canadian Journal of Infectious Diseases and Medical Microbiology. 18: 5A-7A+16A-18A. |
0.045 |
|
| 2014 |
Walmsley S, Osmotherly PG, Rivett DA. Movement and pain patterns in early stage primary/idiopathic adhesive capsulitis: a factor analysis. Physiotherapy. 100: 336-43. PMID 24680792 DOI: 10.1016/j.physio.2014.02.001 |
0.044 |
|
| 2014 |
Thompson AA, Walmsley SR, Whyte MK. A local circadian clock calls time on lung inflammation. Nature Medicine. 20: 809-11. PMID 25100521 DOI: 10.1038/nm.3649 |
0.041 |
|
| 2012 |
Graham AS, Hammond A, Walmsley S, Williams AE. Foot health education for people with rheumatoid arthritis - some patient perspectives. Journal of Foot and Ankle Research. 5: 23. PMID 22937987 DOI: 10.1186/1757-1146-5-23 |
0.04 |
|
| 2013 |
Fermin D, Walmsley SJ, Gingras AC, Choi H, Nesvizhskii AI. LuciPHOr: algorithm for phosphorylation site localization with false localization rate estimation using modified target-decoy approach. Molecular & Cellular Proteomics : McP. 12: 3409-19. PMID 23918812 DOI: 10.1074/Mcp.M113.028928 |
0.04 |
|
| 2017 |
Chen G, Walmsley S, Cheung GC, Chen L, Cheng CY, Beuerman RW, Wong TY, Zhou L, Choi H. Customized consensus spectral library building for untargeted quantitative metabolomics analysis using data independent acquisition mass spectrometry and MetaboDIA workflow. Analytical Chemistry. PMID 28391692 DOI: 10.1021/Acs.Analchem.6B05006 |
0.039 |
|
| 2007 |
Gaines PJ, Powell TD, Walmsley SJ, Estredge KL, Wisnewski N, Stinchcomb DT, Withrow SJ, Lana SE. Identification of serum biomarkers for canine B-cell lymphoma by use of surface-enhanced laser desorption-ionization time-of-flight mass spectrometry. American Journal of Veterinary Research. 68: 405-10. PMID 17397297 DOI: 10.2460/Ajvr.68.4.405 |
0.038 |
|
| 2009 |
Walmsley S, Rivett DA, Osmotherly PG. Adhesive capsulitis: Establishing consensus on clinical identifiers for stage 1 using the delphi technique Physical Therapy. 89: 906-917. PMID 19589853 DOI: 10.2522/ptj.20080341 |
0.038 |
|
| 2015 |
Dougherty J, Walmsley S, Osmotherly PG. Passive range of movement of the shoulder: a standardized method for measurement and assessment of intrarater reliability. Journal of Manipulative and Physiological Therapeutics. 38: 218-24. PMID 25704219 DOI: 10.1016/j.jmpt.2014.11.006 |
0.038 |
|
| 2020 |
Guo J, Turesky RJ, Tarifa A, DeCaprio AP, Cooke MS, Walmsley SJ, Villalta PW. Development of a DNA Adductome Mass Spectral Database. Chemical Research in Toxicology. PMID 32223224 DOI: 10.1021/Acs.Chemrestox.0C00031 |
0.038 |
|
| 2007 |
Walmsley SA, Leslie RW, Sauer WHH. Bycatch and discarding in the South African demersal trawl fishery Fisheries Research. 86: 15-30. DOI: 10.1016/j.fishres.2007.03.002 |
0.035 |
|
| 2016 |
Jones R, McDonald KE, Willson JA, Ghesquière B, Sammut D, Daniel E, Harris AJ, Lewis A, Thompson AA, Dickinson RS, Plant T, Murphy F, Sadiku P, Keevil BG, Carmeliet P, ... ... Walmsley SR, et al. Mutations in succinate dehydrogenase B (SDHB) enhance neutrophil survival independent of HIF-1α expression. Blood. PMID 27006389 DOI: 10.1182/blood-2016-02-696922 |
0.034 |
|
| 2004 |
Walmsley SJ, Gaines PJ. Identification of two cDNAs encoding synaptic vesicle protein 2 (SV2)-like proteins from epithelial tissues in the cat flea, Ctenocephalides felis Insect Molecular Biology. 13: 225-230. PMID 15157223 DOI: 10.1111/J.0962-1075.2004.00478.X |
0.032 |
|
| 2003 |
Gaines PJ, Walmsley SJ, Wisnewski N. Cloning and characterization of five cDNAs encoding peritrophin-A domains from the cat flea, Ctenocephalides felis Insect Biochemistry and Molecular Biology. 33: 1061-1073. PMID 14563358 DOI: 10.1016/S0965-1748(03)00096-1 |
0.032 |
|
| 2014 |
Walmsley S, Osmotherly PG, Rivett DA. Clinical identifiers for early-stage primary/idiopathic adhesive capsulitis: are we seeing the real picture? Physical Therapy. 94: 968-76. PMID 24652474 DOI: 10.2522/ptj.20130398 |
0.032 |
|
| 2007 |
Coutlée F, Rouleau D, Ghattas G, Hankins C, Vézina S, Coté P, Macleod J, De Pokomandy A, Money D, Walmsley S, Voyer H, Brassard P, Franco E. Confirmatory real-time PCR assay for human papillomavirus (HPV) type 52 infection in anogenital specimens screened for HPV infection with the linear array HPV genotyping test Journal of Clinical Microbiology. 45: 3821-3823. PMID 17898159 DOI: 10.1128/Jcm.01145-07 |
0.031 |
|
| 2015 |
Walmsley S. ACP Journal Club: review: Xpert MTB/RIF assay detects extrapulmonary TB in lymph nodes and CSF, but not pleural fluid. Annals of Internal Medicine. 162: JC11. PMID 25686186 DOI: 10.7326/Acpjc-2015-162-4-011 |
0.03 |
|
| 2013 |
Bolton CE, Bevan-Smith EF, Blakey JD, Crowe P, Elkin SL, Garrod R, Greening NJ, Heslop K, Hull JH, Man WD, Morgan MD, Proud D, Roberts CM, Sewell L, Singh SJ, ... ... Walmsley S, et al. British Thoracic Society guideline on pulmonary rehabilitation in adults. Thorax. 68: ii1-30. PMID 23880483 DOI: 10.1136/thoraxjnl-2013-203808 |
0.027 |
|
| 2010 |
Tan DH, Walmsley SL. Response to Stegmann s, et Al. [J. Clin. Virol. 47 (1) (2010) 79-81]. Journal of Clinical Virology : the Official Publication of the Pan American Society For Clinical Virology. 47: 297-8. PMID 20079687 DOI: 10.1016/j.jcv.2009.12.016 |
0.025 |
|
| 2010 |
Parkes G, Young JA, Walmsley SF, Abel R, Harman J, Horvat P, Lem A, Macfarlane A, Mens M, Nolan C. Behind the signs-a global review of fish sustainability information schemes Reviews in Fisheries Science. 18: 344-356. DOI: 10.1080/10641262.2010.516374 |
0.018 |
|
| 2007 |
Pannucci L, Walmsley SA. Supporting learning-disabled adults in literacy Journal of Adolescent and Adult Literacy. 50: 540-546. DOI: 10.1598/JAAL.50.7.3 |
0.018 |
|
| 2012 |
Walmsley S, Rivett DA, Osmotherly PG, McKiernan ST. Early diagnosis of primary/idiopathic adhesive capsulitis: Can imaging contribute? International Musculoskeletal Medicine. 34: 166-174. DOI: 10.1179/1753615412Y.0000000010 |
0.018 |
|
| 2010 |
Ten Hallers-Tjabbes CC, Walmsley S. Consequences of Antifouling Systems - An Environmental Perspective Biofouling. 243-251. DOI: 10.1002/9781444315462.ch17 |
0.013 |
|
| 2011 |
Walmsley S. Oxygen and blood gas sampling in the community Practice Nurse. 41: 41-45. |
0.011 |
|
| 2008 |
Walmsley S, Bottom J. How can a blind engineer access the curriculum? Proceedings of the 7th European Conference On E-Learning, Ecel 2008. 2: 630-635. |
0.011 |
|
| 2007 |
Bustard D, Hassan S, McSherry D, Walmsley S. GRAPHIC illustrations of autonomic computing concepts Innovations in Systems and Software Engineering. 3: 61-69. DOI: 10.1007/s11334-006-0013-9 |
0.01 |
|
| 2006 |
Bustard D, Hassan S, McSherry D, Walmsley S. Standard exemplars for autonomic computing concepts Proceedings - Third Ieee International Workshop On Engineering of Autonomic and Autonomous Systems, Ease 2006. 2006: 47-53. DOI: 10.1109/EASE.2006.13 |
0.01 |
|
| Hide low-probability matches. |